Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Anthony San Lucas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Genetic Epidemiology|December 20, 2018
System for Quality-Assured Data Analysis: Flexible, reproducible scientific workflowsJerry Fowler, Francis Anthony San Lucas, Paul Scheet
Journal of Clinical Pathology|May 6, 2021
Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapyErin Faber, Horiana Grosu, Sharjeel Sabir, et al.
Cancer Cytopathology|March 27, 2026
Unraveling the nexus: Tumor mutational burden, PD-L1 expression, and oncogenic alterations in non-small cell lung cancer cytology specimensMin Dai, Francis Anthony San Lucas, Hector Alvarez, et al.
British Journal of Cancer|March 31, 2021
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancerAlexander Semaan, Vincent Bernard, Dong U Kim, et al.
JCO Precision Oncology|February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Genetic Epidemiology|December 20, 2018
System for Quality-Assured Data Analysis: Flexible, reproducible scientific workflowsJerry Fowler, Francis Anthony San Lucas, Paul Scheet
Journal of Clinical Pathology|May 6, 2021
Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapyErin Faber, Horiana Grosu, Sharjeel Sabir, et al.
Cancer Cytopathology|March 27, 2026
Unraveling the nexus: Tumor mutational burden, PD-L1 expression, and oncogenic alterations in non-small cell lung cancer cytology specimensMin Dai, Francis Anthony San Lucas, Hector Alvarez, et al.
British Journal of Cancer|March 31, 2021
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancerAlexander Semaan, Vincent Bernard, Dong U Kim, et al.
JCO Precision Oncology|February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Pageof 1